Vertex Pharmaceuticals Incorporated VRTX
Transcripts49
Date range2013-04-30 – 2025-05-05
Calls charted49
Sentiment timeline
Net Loughran-McDonald sentiment per call (×1000), earliest → latest.
CEO vs CFO
Average sentiment of each executive's remarks per call. Divergence is a signal.
Prepared remarks vs Q&A
Scripted tone vs unscripted answers. The gap is information.
Prepared remarksQ&A responses
Tone vs forward expectations
Management tone next to Wall Street's forward-looking numbers (glopardo): the 12-month forward EPS estimate and the forward P/E per call.
Forward EPS estimate
Forward P/E
Divergence watch ⚑
Quarters where tone and the forward EPS estimate moved opposite ways.
- 2014 Q3
tone ↓ -6.3
fwd EPS ↑ +0.49
Tone cooled even as the forward EPS estimate rose.
- 2015 Q1
tone ↓ -4.2
fwd EPS ↑ +0.26
Tone cooled even as the forward EPS estimate rose.
- 2015 Q4
tone ↓ -5.0
fwd EPS ↑ +0.71
Tone cooled even as the forward EPS estimate rose.
- 2019 Q3
tone ↓ -3.4
fwd EPS ↑ +0.56
Tone cooled even as the forward EPS estimate rose.
- 2020 Q1
tone ↓ -3.8
fwd EPS ↑ +1.63
Tone cooled even as the forward EPS estimate rose.
- 2020 Q4
tone ↓ -5.0
fwd EPS ↑ +0.57
Tone cooled even as the forward EPS estimate rose.
- 2021 Q4
tone ↓ -5.5
fwd EPS ↑ +0.52
Tone cooled even as the forward EPS estimate rose.
- 2023 Q1
tone ↑ +2.9
fwd EPS ↓ -1.30
Tone rose while the forward EPS estimate was cut.
- 2023 Q3
tone ↓ -2.1
fwd EPS ↑ +0.57
Tone cooled even as the forward EPS estimate rose.
- 2024 Q1
tone ↓ -5.3
fwd EPS ↑ +0.78
Tone cooled even as the forward EPS estimate rose.
Recent transcripts
| Call | Date | Sentiment ×1000 | Fwd EPS | Fwd P/E | |
|---|
| 2025 Q1 | 2025-05-05 | +8.1 | — | — | View → |
| 2024 Q4 | 2025-02-10 | +6.4 | — | — | View → |
| 2024 Q3 | 2024-11-04 | +7.5 | $13.38 | 35.4 | View → |
| 2024 Q2 | 2024-08-01 | +5.9 | $17.62 | 26.5 | View → |
| 2024 Q1 | 2024-05-06 | +3.8 | $17.13 | 24.1 | View → |
| 2023 Q4 | 2024-02-05 | +9.0 | $16.35 | 24.8 | View → |
| 2023 Q3 | 2023-11-06 | +7.2 | $15.84 | 21.9 | View → |
| 2023 Q2 | 2023-08-01 | +9.3 | $15.28 | 22.3 | View → |